Skip to main content
. Author manuscript; available in PMC: 2016 Jun 13.
Published in final edited form as: JAMA Surg. 2015 Oct;150(10):931–940. doi: 10.1001/jamasurg.2015.1534

Figure 1. Prevalence of any remission (partial or complete) by treatment group and year.

Figure 1

aPartial remission of T2DM - no use of antidiabetics, hemoglobin A1c (HbA1c) level of less than 6.5%, and fasting plasma glucose (FPG) level of125 mg/dL or less

Complete remission of T2DM - no use of antidiabetics, HbA1c level of less than 5.7%, and FPG level of 100mg/dL or less

Missing data at follow-up were assumed to be no remission.

RYGB = Roux-en-Y gastric bypass, LAGB = laparoscopic gastric banding, LWLI = Lifestyle weight loss intervention (intensive)

The test of the difference between treatment group p-values are calculated for each time point as follows: year 1 p = <0.0001, year 2 p<0.0001, year 3 p = 0.0037.